Couverture de Signal and Symptoms Podcast

Signal and Symptoms Podcast

Signal and Symptoms Podcast

De : Harvey Castro MD Junaid Kalia MD & Edward Marx
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
Three healthcare AI experts who've watched millions wasted on failed projects. Dr. Harvey Castro, Dr. Junaid Kalia, Edward Marx, and guest experts cover all things healthcare AI - from digital transformation to clinical reality. Every Tuesday, we diagnose real failures, reveal what actually works, and help you avoid the expensive mistakes we've seen repeated everywhere. Because when AI decisions affect patient care, getting it right isn't optional.Copyright 2026 Harvey Castro MD, Junaid Kalia MD, & Edward Marx Hygiène et vie saine Maladie et pathologies physiques Politique et gouvernement
Épisodes
  • Healthcare AI in Fall 2026: What Changed and Why It Matters
    Oct 2 2026

    No guest this week, just the two besties going deep. Dr. Junaid Kalia and DR GPT™ Harvey Castro step back to ask what actually changed in healthcare AI this fall, and why it matters. They land on two shifts pulling in the same direction. Junaid’s is technical and under-reported: we have started building AI models for machines, not humans, systems that return a calibrated decision and a probability instead of paragraphs of text, running an entire EHR as a “decision machine” in seconds and at a fraction of the cost. Harvey’s is human and personal: the move from reactive to proactive medicine, built around the one metric he argues beats almost everything else, your VO2 max. One of them lost his father to an emergency that started silently years earlier. The thesis that ties it together: the best emergency is the one that never comes.

    What You Will Discover:
    • Cold open: what if your emergency has already started? (DR GPT™ Harvey Castro)
    • The shift: we are building AI for machines, not humans (Junaid)
    • Reactive vs proactive medicine, and why it is personal (DR GPT™ Harvey Castro)
    • VO2 max: the longevity metric that beats fixing diabetes (DR GPT™ Harvey Castro)
    • Men’s health, and why men die sooner (Junaid)
    • Self-evolving research agents and “benchmark as teacher” (Junaid)
    • Why SaveLife.AI™ now runs its own GPUs (Junaid)
    • Decisions, not language: building AI for outcomes (Junaid)
    • Warfarin and the EHR as a decision machine (Junaid)
    • 600 questions on one chart, in under a second (Junaid)
    • The close: take care of your body today (DR GPT™ Harvey Castro)

    Referenced in the show:

    🖇️ Calibrated “decision” models: System-1-style systems that return a choice and a probability instead of text (product and company names were spoken on-air; verify spelling before citing)

    🖇️ Small, knowledge-light models (e.g., the MiniCPM family) as fast decision engines

    🖇️ SaveLife.AI™ bringing its own GPUs online

    🖇️ VO2 max and cardiorespiratory fitness as a mortality predictor

    🖇️ Daily steps and longevity (the 7,500-step discussion)

    🖇️ Signal & Symptoms Ep 54 (Dr. Alan Weiss): genetic testing at scale

    Connect with us:

    Dr. Junaid Kalia, Neurocritical Care Specialist and Founder of SaveLife.AI™ (host)

    💼 LinkedIn: https://www.linkedin.com/in/junaidkaliamd

    🔗 Website: https://www.junaidkalia.com/

    📹 YouTube: https://www.youtube.com/@junaidkaliamd

    DR GPT™ Harvey Castro, ER Physician (co-host)

    💼 LinkedIn: https://www.linkedin.com/in/harveycastromd/

    🔗 Website: https://www.harveycastromd.com/

    Visit our website: https://signalandsymptoms.com/

    Get advisory insights about Healthcare AI, at zero cost: https://junaidkaliamd.substack.com/

    Medical disclaimer: This conversation is for general informational purposes and is not medical advice. Listening does not create a doctor and patient relationship. The longevity and fitness points are general wellness information, not a treatment plan; talk to your own clinician before changing exercise or health routines. Views expressed are the hosts’ own and do not represent their employers. No PHI is shared.

    Afficher plus Afficher moins
    10 min
  • Should You Know What You Can’t Fix? Genetic Testing at Scale, with Dr. Alan Weiss
    Sep 29 2026

    The cost of sequencing your genome just fell below $100, so the hard question is no longer “can we test?” It is “should you know what you cannot fix?” That is the tension at the center of this episode, and the panel refuses to give it an easy answer.

    Dr. Alan Weiss, Senior Vice President of Clinical Advancement at Banner Health, returns to Signal & Symptoms (his second appearance) for a conversation on genetic testing at scale, hosted by Dr. Junaid Kalia with co-hosts Dr. Isha Mannering, DR GPT™ Harvey Castro, and Edward Marx. Alan tells the story of a colleague, a genuine health specimen, who did a consumer panel and learned she carries risk for a rare, untreatable cancer, turning her overnight into one of the “worried well.” Harvey shares finding his own macular-degeneration gene during a chess game with his grandfather, and later, how CRISPR let a sickle-cell patient climb a mountain. Junaid raises the Apple Watch AFib problem, where a screening tool floods the system faster than it can absorb. Isha holds the line that genetics is still just a tool, and that newborn screening is where universal testing clearly wins. And Alan closes the loop with a confession: offered widespread testing himself, he said no.

    What You Will Discover:
    • Cold open: CRISPR, and a gene you cannot unknow
    • A gene you can’t unknow
    • Welcome back Dr. Alan Weiss: genetics, genomics, and AI
    • A grandfather, chess, and a risk gene (DR GPT™ Harvey Castro)
    • The cost just fell below $100 02:08 The “worried well”: a healthy colleague, a frightening result
    • Information vs wisdom: knowing what NOT to do
    • Pharmacogenomics: the codeine metabolizer example
    • Offer it, or patients get it elsewhere (Edward Marx)
    • The Apple Watch AFib problem
    • Genetics is still just a tool (Dr. Isha Mannering)
    • Does knowing your risk change behavior? The back-pain paradox
    • CISPR let a sickle-cell patient climb a mountain (DR GPT™ Harvey Castro)
    • Newborn screening: where testing clearly wins
    • “I was offered testing, and I said no”

    Referenced in the show:

    🖇️ The sub-$100 genome and the falling cost curve of sequencing

    🖇️ Pharmacogenomics: the fast-metabolizer / codeine safety example

    🖇️ The Apple Watch AFib screening surge and screening-to-diagnostic capacity

    🖇️ CRISPR and sickle cell disease

    🖇️ State-mandated newborn screening and the move toward genomic newborn screening

    🖇️ Signal & Symptoms Ep 52 (Dr. Alan Weiss, first appearance): the empathy debate

    Connect with us:

    Dr. Junaid Kalia, Neurocritical Care Specialist and Founder of SaveLife.AI™ (host)

    💼 LinkedIn: https://www.linkedin.com/in/junaidkaliamd

    🔗 Website: https://www.junaidkalia.com/

    📹 YouTube: https://www.youtube.com/@junaidkaliamd

    Dr. Isha Mannering (co-host)

    💼 LinkedIn: https://www.linkedin.com/in/isha-mannering

    DR GPT™ Harvey Castro, ER Physician (co-host)

    💼 LinkedIn: https://www.linkedin.com/in/harveycastromd/

    Edward Marx, CEO, Advisor (co-host)

    💼 LinkedIn: https://www.linkedin.com/in/edwardmarx/ 🔗 Website: https://www.marxadvisory.com/

    Special Guest:

    Dr. Alan M. Weiss, MD, MBA, FACP, Senior Vice President of Clinical Advancement, Banner Health (physician-informaticist; former CMIO)

    💼 LinkedIn: https://www.linkedin.com/in/dralanmweiss/

    Visit our website: https://signalandsymptoms.com/

    Get advisory insights about Healthcare AI, at zero cost: https://junaidkaliamd.substack.com/

    Medical disclaimer: This conversation is for general informational purposes and is not medical advice. Listening does not create a doctor and patient relationship. Views expressed by the guest and co-hosts are their own and do not represent their employers. Genetic and screening decisions should be made with a qualified clinician and, where appropriate, a genetic counselor. No specific company or test is endorsed. No PHI is shared.

    Afficher plus Afficher moins
    9 min
  • Making Care Make Sense: AI, Fragmentation, and the Patient in the Middle, with Dr. Kaitlan Baston (Vinyl Health)
    Sep 21 2026
    Less than half of what a doctor says in a visit is remembered. You cannot fix that with a better algorithm alone, but you can fix the record. That is Dr. Kaitlan Baston’s whole thesis: “We aren’t necessarily fixing universal healthcare, but we are fixing the universal record, and making sure the patient is at the center.”Dr. Kaitlan Baston, Founder and CEO of Vinyl Health and a former New Jersey Health Commissioner, joins host Dr. Junaid Kalia with co-hosts Dr. Isha Mannering, DR GPT™ Harvey Castro, and Edward Marx. A primary care and addiction physician who once ran a safety-net hospital, she built Vinyl as a personal health assistant for patients and families navigating a fragmented system: it translates the medical record into plain language, takes the visit notes so the patient can actually be present, and hands people back control of their own data. The panel widens the lens from there, to the 70% of medical data still moving by fax, what Taiwan gets right about same-day access, Harvey’s personal digital twin, and why data you get for free makes you the product.What You Will Discover:Cold open: fix the universal record, not (yet) universal healthcareMeet Dr. Kaitlan Baston: from integrated care to Vinyl HealthThe EHR as a “junk drawer” (the education that never makes the note)The chaotic clinic visit (Dr. Isha Mannering)Vinyl’s AI note-taker: be present, walk out with a summary and to-dosThe doctor-in-the-loop summary page and the human connectionCare-management duplication and the “I need a ride” fix16 channels, and the 70% of medical data still faxedWhat Taiwan gets right: same-day access, longer life, a third the costHarvey’s personal digital twin (DR GPT™ Harvey Castro)Inside a top AI health system: Nebraska Medicine (Edward Marx)Own your data: when it’s free, you are the productYour record for $2, and the case for physician-led AIReferenced in the show:🖇️ Vinyl Health: a personal health assistant that turns the record into plain language (https://www.vinylhealth.ai/)🖇️ The “junk drawer” EHR and the patient-held, patient-controlled record🖇️ Taiwan’s single-payer system: same-day walk-in access at roughly a third of US cost as a share of GDP🖇️ eFax in medicine: most records still move by fax in 2026🖇️ Signal & Symptoms Ep 52 (Dr. Alan Weiss): the empathy debateConnect with us:Dr. Junaid Kalia, Neurocritical Care Specialist and Founder of SaveLife.AI™ (host)💼 LinkedIn: https://www.linkedin.com/in/junaidkaliamd 🔗 Website: https://www.junaidkalia.com/📹 YouTube: https://www.youtube.com/@junaidkaliamdDr. Isha Mannering (co-host)💼 LinkedIn: https://www.linkedin.com/in/isha-manneringDR GPT™ Harvey Castro, ER Physician (co-host)💼 LinkedIn: https://www.linkedin.com/in/harveycastromd/Edward Marx, CEO, Advisor (co-host)💼 LinkedIn: https://www.linkedin.com/in/edwardmarx/🔗 Website: https://www.marxadvisory.com/Special Guest:Dr. Kaitlan Baston, MD, MSc, Founder & CEO of Vinyl Health (former New Jersey Health Commissioner; former President & CEO, University Hospital, Newark)💼 LinkedIn: https://www.linkedin.com/in/kaitlan-baston/🔗 Vinyl Health: https://www.vinylhealth.ai/Visit our website: https://signalandsymptoms.com/Get advisory insights about Healthcare AI, at zero cost: https://junaidkaliamd.substack.com/Medical disclaimer: This conversation is for general informational purposes and is not medical advice. Listening does not create a doctor and patient relationship. Views expressed by the guest and co-hosts are their own and do not represent their employers. Tools discussed are patient-support and decision-support with a clinician in the loop, not autonomous or cleared diagnostic devices. No PHI is shared.
    Afficher plus Afficher moins
    10 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment